Skip Navigation

Advertise|Press|Contact|FAQ|About Us


Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Disease Category: Bipolar Disorder
Location: United States, IL

Clinical Trial Details


Research Study Summary

Preventing the Recurrence of Depression in Bipolar Disorder


This study compares combination treatment with a mood stabilizer plus an antidepressant to treatment with the mood stabilizer alone and to gather information about the safety, tolerability and frequency of mood changes during continuation treatment. The purpose is to collect information about whether the combination treatment results in fewer returns of depressive symptoms compared to treatment with the mood stabilizer alone. Both study drugs are FDA-approved. Study participation can last up to 62 weeks.

Inclusion Criteria

  • Men and women
  • 18 years of age or older
  • Diagnosis of bipolar disorder, currently experiencing a depressive episode
  • Able to read, write and understand English

Exclusion Criteria

  • Current alcohol or drug abuse, or alcohol or drug dependence within the past 3 months
  • Known sensitivity to (or unable to take) either study drug
  • Unstable medical condition or use of certain other medications
  • Pregnant or nursing women, or women of child-bearing potential who are unwilling to use a medically acceptable form of contraception
  • Actively suicidal or requiring hospitalization

To Learn more

Both Male and Female


18 and up

Overall Status



62 Weeks

Facility Type



Linda Skaggs
Rush University Medical Center - Treatment Research Center
1700 W. Van Buren Street, 5th Floor
Chicago, IL 60612
Phone: 312-980-6356
Fax: 312-942-2177

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Zip/Postal Code:
Please leave this field empty.

CW ID: 164482

Date Last Changed: July 24, 2013

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.